Search Results - "Johnson, Gordon F"

Diagnostic guidelines for bipolar depression: a probabilistic approach by Mitchell, Philip B, Goodwin, Guy M, Johnson, Gordon F, Hirschfeld, Robert MA

“…Objectives:  There are currently no accepted diagnostic criteria for bipolar depression for either research or clinical purposes. This paper aimed to develop…”
Get full text

Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects by O'Sullivan, Brendan T., Cutler, David J., Hunt, Glenn E., Walters, Craig, Johnson, Gordon F., Caterson, Ian D.

“…The pharmacokinetics of dexamethasone (DEX) were studied in 9 drug-free melancholically depressed patients and 10 healthy control subjects matched by sex and…”
Get full text

Clozapine treatment in Australia: a review of haematological monitoring by Copolov, David L, Bell, William R, Keks, Nicholas A, Strazzeri, Diane C, Benson, Warwick J, Johnson, Gordon F

“…BackgroundClozapine is an atypical antipsychotic drug indicated for patients with schizophrenia in whom traditional antipsychotic drugs (such as haloperidol or…”
Get full text

Lithium neurotoxicity by Johnson, G F

“…One of the most alarming and potentially serious complications of Lithium Carbonate therapy is the emergence of central nervous system toxicity. This paper…”
Get more information

LSD in the treatment of alcoholism by Johnson, F G

Get more information

Career Education for the Mentally Retarded by JOHNSON, GORDON F.

Get full text

MEASURING THE INCIDENCE OF SELF-INJURY: Some Methodological and Design Considerations by Whitehead, Paul C., Johnson, F. Gordon, Ferrence, Roberta

“…Self-injury behavior in a city of some 200,000 residents was measured in a study designed to employ a wider variety of sources of information than had previous…”
Get full text

The ecology of self-injury: a multivariate approach by Jarvis, G K, Ferrence, R G, Whitehead, P C, Johnson, F G

“…In an ecological study of the distribution of self-injury in London, Canada, the authors found that self-injury occurred more frequently in the central areas…”
Get more information

Career tryout project: working with mentally retarded patients in a state hospital setting by Johnson, G F

Get more information

Factors affecting reported rates of self-injury by Ferrence, R G, Johnson, F G

Get more information

Drinking and self-injury: toward untangling the dynamics by Frankel, B G, Ferrence, R G, Johnson, F G, Whitehead, P C

Get more information

Sex and Age Patterns in Self-Injury by Jarvis, George K., Ferrence, Roberta G., Johnson, F. Gordon, Whitehead, Paul C.

“…Age and sex differences in rates of self-injury are prominent and relatively unexplained. A prospective study of self-injury patients resident in London,…”
Get full text

Self-injury. Identification and intervention by Johnson, F G, Ferrence, R, Whitehead, P C

Get more information

THE HISTORY OF PUBLIC HEALTH IN CANADA by Johnson, F. Gordon

Get full text

Analysis of familial factors in bipolar affective illness by Johnson, G F, Leeman, M M

“…Familial transmission of affective illness was studied using a family interview and family history method in a group of 35 bipolar manic-depressive patients…”
Get more information

Personality types among alcoholics by Partington, J T, Johnson, F G

Get more information

Psychotropics, A to Z by Johnson, Gordon F S

Get full text

Lithium in depression: a review of the antidepressant and prophylactic effects of lithium by Johnson, G F

“…The therapeutic effects of lithium in depression are reviewed. The acute antidepressant effect of lithium alone is neither as impressive nor as predictable as…”
Get more information

The plasma dexamethasone "window" and the dexamethasone suppression test in depression by Johnson, G F, Hunt, G, Kerr, K, Caterson, I

Get more information

The plasma dexamethasone window: evidence supporting its usefulness to validate dexamethasone suppression test results by O'Sullivan, B T, Hunt, G E, Johnson, G F, Caterson, I D

“…Two doses of dexamethasone (DEX) (0.5 and 1.0 mg) were administered in a randomized crossover design to 31 patients with major depression, 9 healthy controls,…”
Get more information